In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous…
Uncategorized
VIDEO: Subretinal fluid seen as ‘protective’ against development of macular atrophy
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Brandon G. Busbee, MD, reports on risk factors associated with development of macular atrophy as determined by 2-year ad hoc findings from the HARBOR trial, in which the presence of subretinal fluid in the baseline population “seemed to be protective” against development of macular atrophy.
Uncategorized
Research and Markets: Global Ocular Hypertension Pipeline Review H2 2015 – 17 Companies & 27 Drug Profiles
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/h4zm8f/ocular) has announced the addition of the “Ocular Hypertension – Pipeline Review, H2 2015” report to their offering.This report provides comprehensive info…
Halteres, essential for flight in all flies, are needed by some to climb walls
Sensory organ use hints at how brain processes multiple sources of information.
Stem cell study paves the way for patient therapies
Stem cells that have been specifically developed for use as clinical therapies are fit for use in patients, an independent study of their genetic make-up suggests.
Uncategorized
Single dose of bimatoprost ocular insert demonstrates IOP reduction in glaucoma, ocular hypertension
LAS VEGAS — A single dose of a novel topical bimatoprost ocular insert demonstrated sustained IOP reduction in patients with glaucoma and ocular hypertension at 6 months, according to phase 2 study results presented here. “Despite highly effective topical treatments, half of our patients stop using their drops by 1 year, and among those who do continue to use their drops, many of them have difficulty using them properly. … There is a pressing need for sustained patient behavior independent delivery of glaucoma medications to prevent blindness,” James D. Brandt, MD, said at the American Academy of Ophthalmology annual meeting.